Deloitte November 26, 2014
Jason Girzadas

Digital manufacturing and nanotechnology…Synthetic biology…Artificial intelligence and advanced robotics…Crowd-sourcing…Incentive competitions…Health and medicine are not immune from the rapid change of technology. Moore’s Law is at work with exponential improvements in performance and a corresponding drop in cost, making innovations possible like never before. The question is, “What impact will these exponential changes have on organizations’ businesses and ecosystems? And, what new business models will the technologies create?”
Earlier this month, Deloitte Consulting LLP’s Life Sciences and Health Care practice worked with the Deloitte Consulting Innovation (DCI) team on a unique collaboration with one of our newest strategic partners – Singularity University – to host Exponential Medicine 2014. Exponential Medicine is a global workshop of more than 400 thinkers, innovators, entrepreneurs,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health IT, Uncategorized
Humana names CIO
Epic's top 10 moves of '24
Interoperability resistance is a change management issue
ASTP finalizes information blocking exception for reproductive health
Epic's 2025 priorities

Share This Article